Navigation Links
The Leukemia & Lymphoma Society's "A Tribute to Jackie" Photo Collection Part of Auction Commemorating the 50th Anniversary of President Kennedy's Assassination
Date:11/21/2013

WHITE PLAINS, N.Y., Nov. 21, 2013 /PRNewswire/ -- A striking collection of framed photographs owned by The Leukemia & Lymphoma Society (LLS) of former First Lady Jacqueline Kennedy, both alone and accompanied by President John Kennedy, and other family members, is part of a major auction taking place in Amesbury, Mass., to commemorate the 50th anniversary of the assassination of President Kennedy.

The Legends Auction – President John F. Kennedy and His Contemporaries – Documents, Photography, Letters and Gifts will take place at McInniss Auction House beginning on Friday, November 22, 2013, which is the 50th anniversary of President Kennedy's assassination in Dallas.

The collection of 55 photographs was taken by Jacques Lowe, the former first family's personal photographer. LLS acquired the collection from Lowe several years after the former First Lady's death from non-Hodgkin lymphoma in May 1994. The proceeds from the sale of the photographs in the collection will benefit LLS's quest to find cures and ensure access to treatments for blood cancer patients.

"It is a fitting legacy for LLS to offer these photographs on the solemn occasion of the 50th anniversary," said LLS chief marketing officer Lisa Stockmon. "In light of the former First Lady's death as a result of a blood cancer, and with heightened attention focused once again on the Kennedy legacy, it is our hope that this collection will help raise awareness of how LLS is advancing new therapies for patients with blood cancer, and raise funds that can be invested in cutting-edge research to find cures and better treatments."

Please visit

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Actinium Pharmaceuticals Acute Myeloid Leukemia Clinical Data to be Presented Today at 8th International Symposium on Targeted Alpha Therapy Conference
2. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
3. Medical Scientist Discovers an Alternative Treatment for Leukemia Using Alkaline Ionized or Electrolyzed Reduced Drinking Water
4. The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
5. Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 and Phase 2 Trials Suggest High and Durable Response in Chronic Lymphocytic Leukemia
6. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
7. Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
8. Global Acute Myeloid Leukemia (AML) Therapeutics Industry
9. The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
10. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
11. Study of Cell Therapeutics Tosedostat for Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Now Enrolling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 2, 2015  Pfenex Inc. (NYSE MKT: ... development of biosimilar therapeutics, today announced that it ... Healthcare Conference in Miami, FL at the Loews Miami Beach ... officer of Pfenex, will provide an overview of ... 12th at 9:00 am ET. A live audio webcast and ...
(Date:3/2/2015)... 2015 Editor Note: For more ... Moments ago, Analysts Review released new research updates ... (NASDAQ: SSH ), Synergetics USA ... ELOS ), Spectranetics (NASDAQ: SPNC ), and ... single unified platform for investors, to hear about what matters ...
(Date:3/2/2015)... SANTA BARBARA, Calif. , March 2, 2015 ... a biotechnology company developing therapies for autoimmune and ... Trademark Office (USPTO) has issued an important new ... immune system function through the targeting of CLIP. ... the targeted peptide technology underlying VG Life Sciences, ...
(Date:3/2/2015)... Global Stem Cells Group.com ... Shenzhen HANK Bioengineering Co., Ltd. and its Chinese-American ... establish a stem cells training course in the ... 2015. , Shenzhen HANK is a biotechnology company ... microbiologist and virologist, to integrate research, development, production, ...
Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3
... Launch Interactive, Case-Based Website on Cardiovascular Disease for ... Whether it,s a common heart condition or a ... similar patient. That,s why the Society for Cardiovascular ... Inc. (EVF), an IC Sciences Company, today unveiled ...
... iZumi Bio, Inc., a biotechnology company focused on ... technology with the mission of creating new therapeutics ... cells, today announced the appointments of Berta Strulovici, ... Pathak, Ph.D., as vice president of Business Development. ...
... announced successful,completion of the single-day oral dosing part ... patients with its new anti-cancer drug AXL1717,an,insulin-like growth ... the closely related insulin receptor. The study is ... The results showed that a single-day,dosing of AXL1717 ...
Cached Biology Technology:New Website Connects Physicians to Solve Challenging Cases and Share Experiences 2New Website Connects Physicians to Solve Challenging Cases and Share Experiences 3New Website Connects Physicians to Solve Challenging Cases and Share Experiences 4iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 2iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 3Successful Phase I/II Clinical Trial Results From Cancer Patients Treated With Anti-Cancer Drug From Axelar AB 2
(Date:2/24/2015)... Feb. 24, 2015 This report analyzes the worldwide ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle East ... estimates and forecasts are provided for the period 2013 through ... markets. Market data and analytics are derived from primary and ...
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Cepheid to Webcast Upcoming Financial Presentations 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25
... MA.April 25th, 2012Aspera, Inc., creators of next-generation software ... speed, and BGI, the world,s largest genomics research ... have partnered to integrate and deploy the Aspera ... technology with "EasyGenomicsTM", BGI,s latest cloud-based Software as ...
... in state in 1970s; Zoo has monitored for beetle since ... Beetle Conservation; the U.S. Fish & Wildlife Service; the Missouri ... to 600 Zoo-bred American burying beetles for the first ... across the 4,040-acre Wah, Kon-Tah Prairie in Southwest Missouri. ...
... reported to increase risk of developing hepatocellular carcinomas (HCC), independent ... of Hepatology , a journal of the American Association ... 70-fold elevated risk of HCC in those with liver cancer ... hepatitis C (HCV). Liver cancer ranks sixth in ...
Cached Biology News:BGI and Aspera collaborate on high-speed data exchange to advance genome research 2First-ever release of endangered burying beetles in Missouri 2First-ever release of endangered burying beetles in Missouri 3First-ever release of endangered burying beetles in Missouri 4Family history of liver cancer increases risk of developing the disease 2
St. Louis encephalitis Immunogen: St. Louis encephalitis. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse Anti-Gemin2...
5-bromo-2'-deoxyuridine (BrdU) Cell Biology Cell Proliferation Bromodeoxyuridine (BrdU) and Related Products...
Rat CINC-2 alpha/beta Affinity Purified Polyclonal Ab...
Biology Products: